News

2016 Jun 24

Ablation of small renal cancer associated with “significantly lower costs” than either partial or radical nephrectomy

For older patients with small (T1a) renal cancer, percutaneous ablation is associated with much lower costs than partial or radical nephrectomy, according to Adam D. Talenfeld, M.D. Read more

Marcin Imielinski, M.D., Ph.D., computational biologist at Meyer Cancer Center, Weill Cornell Medicine

2016 Jun 22

How precision medicine will shift from research to clinical care

Marcin Imielinski, M.D., Ph.D., discusses the potential of precision medicine or cancer care. Read more

Tessa Cigler, M.D. uses cold caps to preserve hair during chemotherapy

2016 Jun 21

Preventing hair loss from chemotherapy

It was a patient who inspired Tessa Cigler, M.D., to investigate the use of "cold caps" to prevent hair loss during chemotherapy. Read more

2016 Jun 20

Epigenome evolution may play key role in cancer progression

Certain types of cancer may be even more shifty and difficult to target than previously thought, due to continuous changes in cell programming. Read more

2016 Jun 16

Relaxation techniques ease patients' fear, anxiety about radiation treatments

A pilot project in radiation oncology has found that a relaxation wellness intervention can provide relief for anxious patients. Read more

Cancer immunologist Sandra Demaria, M.D., of the Meyer Cancer Center, is using radiation to transform tumors into personalized vaccines

2016 Jun 15

More evidence needed in using radiotherapy with immunotherapy

Despite very promising pre-clinical results and some clinical success, there is still much need to generate solid evidence demonstrating the efficacy of combining radiation with immunotherapy, according to Silvia Formenti, M.D., and Sandra Demaria, M.D. Read more

2016 Jun 12

Cancer drug prices higher in U.S., yet relatively affordable

David Nanus, M.D., discusses a study that examined the relative cost of cancer drugs. Read more

2016 Jun 09

The Pediatric Oncologist Paying It Forward at the Mini 10K

Lisa Roth, M.D., on running a race on behalf of a patient and herself, as a lymphoma survivor. Read more

2016 Jun 07

Chimeric antigen receptor T cells exhibit efficacy in advanced lymphoma

John Leonard, M.D., comments on research into the use of engineered CAR-T cells in the treatment of aggressive lymphomas. Read more

2016 Jun 06

FDA approves drug combo for kidney cancer

Ana Molina, M.D., comments on a new treatment for kidney cancer. Read more

2016 Jun 06

Sharing our collective wisdom at ASCO16

A variety of Meyer Cancer Center research and clinical results were showcased at the ASCO Annual Meeting in Chicago Read more

2016 Jun 06

Innovative immunotherapy more effective in treating an aggressive lymphoma than chemotherapy

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to Adrienne Phillips, M.D. Read more

2016 Jun 06

Biomarker confirms efficacy of early drug switch for prostate cancer patients

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to Scott Tagawa, M.D. and Paraskevi Giannakakou, Ph.D. Read more

2016 Jun 05

Young neurosurgeon embraces new technologies to save lives

Profile of Rohan Ramakrishna, M.D., and some of the novel methods he is using to tackle brain tumors. Read more

2016 Jun 05

CASTOR combination is promising treatment for multiple myeloma

Ruben Niesvizky, M.D., comments on a study that tested a new drug combination (daratumumab+bortezomib+dexamethasone) to treat multiple myeloma Read more

2016 Jun 04

Ongoing study assesses effectiveness of BBI-608

Manish Shah, M.D., gives an update on the progress of the BRIGHTER trial to assess a new drug for advanced gastric cancer. Read more

2016 Jun 04

The messenger matters: Oncologists help patients with advanced cancer better understand their illness

Discussing re-staging scan results with oncologists—rather than other care-team members—may lead to a better understanding of late- or end-stage disease in patients with advanced cancers. Read more

Gastrointestinal oncologist Allyson Ocean of the Meyer Cancer Center

2016 Jun 03

Addition of capecitabine to adjuvant chemotherapy extends survival in pancreatic cancer

Allyson Ocean, M.D., comments on a new drug combination for pancreatic cancer patients. Read more

2016 Jun 03

Cantley named as 'Giant of Cancer Care' finalist

Lewis Cantley, Ph.D., has been recognized by OncLive as a finalist for the 'Giants of Cancer Care' award. Read more

2016 Jun 03

How molecular testing guides treatment in AML

Gail Roboz, M.D., discusses the use of molecular genetics to guide leukemia treatment. Read more

News

Ablation of small renal cancer associated with “significantly lower costs” than either partial or radical nephrectomy

How precision medicine will shift from research to clinical care

Preventing hair loss from chemotherapy

Epigenome evolution may play key role in cancer progression

Relaxation techniques ease patients' fear, anxiety about radiation treatments

More evidence needed in using radiotherapy with immunotherapy

Cancer drug prices higher in U.S., yet relatively affordable

The Pediatric Oncologist Paying It Forward at the Mini 10K

Chimeric antigen receptor T cells exhibit efficacy in advanced lymphoma

FDA approves drug combo for kidney cancer

Sharing our collective wisdom at ASCO16

Innovative immunotherapy more effective in treating an aggressive lymphoma than chemotherapy

Biomarker confirms efficacy of early drug switch for prostate cancer patients

Young neurosurgeon embraces new technologies to save lives

CASTOR combination is promising treatment for multiple myeloma

Ongoing study assesses effectiveness of BBI-608

The messenger matters: Oncologists help patients with advanced cancer better understand their illness

Addition of capecitabine to adjuvant chemotherapy extends survival in pancreatic cancer

Cantley named as 'Giant of Cancer Care' finalist

How molecular testing guides treatment in AML

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters